Detelv Güssow

Title: Detelv Güssow: Innovator in Recombinant Technology

Introduction

Detelv Güssow is a notable inventor based in London, GB. He has made significant contributions to the field of recombinant technology, particularly in the development of novel therapeutic compounds. His work has implications for medical research and drug discovery.

Latest Patents

Detelv Güssow holds 1 patent related to a purified recombinant αβ adhesion receptor. This invention showcases an unimpaired ligand binding activity and outlines a process for preparing a soluble, non-membrane bound receptor using recombinant techniques with a baculovirus-insect cell expression system. The soluble receptor serves as an effective screening tool for new therapeutic compounds that may inhibit the natural αβ adhesion receptor. Potential therapeutic compounds identified through this invention include RGD peptides and non-peptidic compounds that mimic natural ligand epitopes.

Career Highlights

Detelv Güssow is associated with Merck Patent GmbH, where he continues to advance his research and innovations. His work has been pivotal in enhancing the understanding of adhesion receptors and their applications in therapeutic contexts.

Collaborations

Detelv has collaborated with notable colleagues such as Simon Lawrence Goodman and Beate Diefenbach, contributing to a dynamic research environment that fosters innovation.

Conclusion

Detelv Güssow's contributions to recombinant technology and therapeutic development highlight his role as a key innovator in the field. His work not only advances scientific knowledge but also opens new avenues for medical applications.